Nan Fung Group Holdings LTD Karuna Therapeutics, Inc. Transaction History

Nan Fung Group Holdings LTD

  • $103 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$191.53 - $236.82 $3.06 Million - $3.78 Million
-15,951 Reduced 6.6%
225,688 $44.3 Million
Q3 2022

Nov 10, 2022
BUY
$123.79 - $277.42 $1.97 Million - $4.43 Million
15,951 Added 7.07%
241,639 $54.4 Million
Q2 2022

Aug 12, 2022
SELL
$93.97 - $143.33 $857,288 - $1.31 Million
-9,123 Reduced 3.89%
225,688 $28.6 Million
Q2 2021

Sep 22, 2021
BUY
$107.45 - $135.95 $25.2 Million - $31.9 Million
234,811 New
234,811 $26.8 Million

Others Institutions Holding KRTX

# of Institutions
10
Shares Held
332K
Call Options Held
0
Put Options Held
0
View Full List

About Karuna Therapeutics, Inc.

KRTX Quotes by TradingView
  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email